IMPORTANCE Patient-reported outcome (PRO) measures for laser in situ keratomileusis (LASIK) are needed.
The Patient-Reported Outcomes With LASIK (PROWL) project team developed a questionnaire to evaluate PROs for persons undergoing LASIK for myopia, hyperopia, or astigmatism, incorporating existing HRQOL measures and developing new items. This article summarizes the psychometric performance of the instrument in 2 studies of participants undergoing LASIK surgery.
Methods

Study Design
We conducted a literature search and obtained input from an expert panel of ophthalmologists, optometrists, psychometricians, and clinical researchers. Draft items were revised based on input from patients who underwent LASIK and another group of experts. In addition, 9 individuals contemplating LA-SIK surgery and 9 who had LASIK surgery performed between 6 months and 2 years ago participated in interviews in Los Angeles, California, and Washington, DC. Four of the post-LASIK participants were satisfied and 4 were dissatisfied with the results of LASIK surgery (1 unknown). These interviews were used to assess item redundancy, content coverage, recall period, instructions, and format, and to revise items for the PROWL studies.
The PROWL-1 study protocol was approved by the Naval Medical Center San Diego Institutional Review Board (IRB) in compliance with all applicable federal regulations governing the protection of human participants. The PROWL-2 study was conducted under the US Food and Drug Administration Research Involving Human Subjects Committee, a central IRB for 3 sites (20/20 Institute, Indianapolis, Indiana; Durrrie Vision, Overland Park, Kansas; and Vance Thompson Vision, Sioux Falls, South Dakota), and university IRBs for 2 sites (The Johns Hopkins University, Baltimore, Maryland; and Stanford University, Stanford, California). All participants provided written as well as oral informed consent. There was no financial compensation in PROWL-1; PROWL-2 participants received compensation. The PROWL studies are registered at Clinicaltrials.gov (NCT0152629 and NCT01655420 for PROWL-1 and PROWL-2, respectively). Both studies were compliant with the Health Insurance Portability and Accountability Act and complied with the tenets of the Declaration of Helsinki.
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PROWL-1 and PROWL-2 were prospective observational studies. Both enrolled patients planning to undergo LASIK surgery for myopia, hyperopia, or astigmatism. Investigators screened, enrolled, and treated study participants with LA-SIK surgery and followed up participants postoperatively according to their usual clinical practice. PROWL-1 was a singlecenter study of active-duty Navy military personnel; PROWL-2 was a 5-center study of civilians. Participants completed the questionnaires preoperatively and at 1 and 3 months after surgery using a secure website accessed from any computer. PROWL-1 had an additional 6-month postoperative visit with questionnaire administration. PROWL-1 began in August 2011 and was completed May 30, 2014; PROWL-2 began in July 2012 and was completed June 27, 2014. Data were analyzed from June 28, 2014, to October 24, 2016.
Questionnaire
The questionnaire included new items to assess satisfaction with current vision (1 item), satisfaction with LASIK surgery (8 items), and the existence, bothersomeness, and effect on usual activities in the past 7 days of 4 key visual symptoms using polytomous response options: double images (8 items), glare (8 items), halos (8 items), and starbursts (8 items). We used a written definition of the symptom and images to illustrate symptom severity levels.
The questionnaire also included items from the National Eye Institute (NEI) Refractive Error Quality of Life Instrument with 42 items (NEI-RQL-42), 11 ,12 the NEI Visual Function Questionnaire with 25 items (NEI-VFQ-25), 13,14 and the Ocular Surface Disease Index (OSDI). 15 All scales are scored on a 0 to 100 possible range. NEI-RQL-42 scales, NEI-VFQ driving scale, visual symptoms scales, and satisfaction with vision are scored such that a higher score is better; OSDI is scored such that a higher score is worse. Potential threats to the validity of the HRQOL measures were evaluated by assessing optimism (Life Orientation Test-Revised), 16 health proneness (Brien Holden Vision Institute Quality of Life Scale for Myopia), 17 anxiety and depressive symptoms (Patient Health Questionnaire-4), 18 socially desirable response set, 19 and expectations about spectacle use and vision after surgery (6 items). The questions and rationale for their selection are available in eMethods and eTables 1-11 in the Supplement. The PROWL-1 preoperative (baseline) version of the questionnaire included 161 items and the postoperative version contained 129 items. The PROWL-2 baseline questionnaire had 154 items and the postoperative questionnaire included 112 items.
Statistical Analysis
The analytic sample comprised individuals who completed a baseline and at least 1 follow-up questionnaire. Correlations of items with the scale that they represented were estimated and compared with correlations of items with other scales. 20 For these item-scale correlations, we imputed missing item responses using maximum likelihood estimates of the covariance matrix via the expectation-maximization algorithm in SAS, version 9. 4 . 21 We evaluated multi-item scales, including the OSDI dry eye symptoms and environmental triggers (8 items), NEI-RQL-42 clarity of vision (4 items), NEI-RQL-42 near vision (4 items), NEI-RQL-42 far vision (5 items), NEI-RQL-42 glare (2 items), NEI-RQL-42 diurnal vision (2 items), NEI-RQL-42 activity limitations (4 items), NEI-RQL-42 worry (2 items), new items for satisfaction with surgery (8 items), and new symptom items developed for the study: glare (8 items), starbursts (8 items), halos (8 items), and double images (8 items). We estimated descriptive statistics and internal consistency reliability (coefficient α) for multi-item scales. The subsample with repeated questionnaire administrations within 14 days was used to estimate test-retest correlations (productmoment and intraclass). Reliability coefficients of 0.70 or above were considered adequate for group-level comparisons. 22 We evaluated construct validity, using product-moment correlations of vision symptom scores with the satisfaction with LASIK surgery scale (hypothesizing statistically significant, positive associations) and expectations about spectacle use and vision after surgery, optimism, health proneness, depression and anxiety symptoms, and socially desirable responses (hypothesizing nonsignificant correlations). Responsiveness to change was assessed by computing change scores, effect size (change in scores divided by SD at baseline), and 2-tailed, paired t tests of the significance of change. We hypothesized that changes over time would be statistically significant and represent improvement in HRQOL (except for possibly worsening glare and dry eye symptoms). Results were considered statistically significant if the probability was P ≤ .05. Because the number of significant effects is inflated by change, we interpreted our results with this in mind. Table 1 summarizes baseline characteristics of enrolled participants (262 in PROWL-1 and 312 in PROWL-2) and the analytic sample (240 [99.6% response rate] in PROWL-1 and 271 [94.4% response rate] in PROWL-2 among those eligible for the study). The most common reason participants were not included in the analytic sample was not having LASIK surgery (eFigure in the Supplement).
Results
Participant Characteristics
The median age of the 240 PROWL-1 respondents was 27 years (range, 21-52 years). Most participants were nonHispanic white (54.6%), with 20.0% Hispanic, 9.2% nonHispanic black, 9.2% non-Hispanic Asian, and 6.3% who selfidentified as being other race/ethnicity; 20.4% were women. PROWL-2 did not include participants in the analytic sample if they did not complete the preoperative questionnaire (n = 5) or did not complete a postoperative questionnaire (n = 16). The median age of the 271 PROWL-2 respondents was 30 years (range, 21-57 years). Most participants were non-Hispanic white (76.4%), with 3.7% Hispanic, 1.8% non-Hispanic black, 12.2% non-Hispanic Asian, and 5.5% who self-identified as other; 54.2% were women.
Questionnaire Completion Time
The median (interquartile range) self-reported time for questionnaire completion at baseline was 25.00 (20.00-35.00) and Scale Descriptive Statistics and Reliability Estimates Table 2 provides baseline scale descriptive statistics and reliability estimates. For most scales, a higher score indicated better HRQOL. Exceptions were the OSDI symptom and environment scales, where higher scores indicated worse symptoms. Ceiling effects (indicating healthiest possible responses) were noteworthy (≥40%) for the NEI-RQL-42 diurnal vision scale and for the visual symptoms scales (double images, glare, halos, and starbursts).
Reliabilities (Cronbach coefficient α) ranged from 0.55 (NEI-RQL-42 glare scale) to 0.98 (new visual symptoms glare scale) in PROWL-1 and 0.65 (NEI-RQL-42 glare scale) to 0.97 (new visual symptoms glare, starbursts, and halos scales) in PROWL-2. The α values for other multi-item scales were as follows in PROWL-1 and PROWL-2, respectively: expectations about spectacle independence and vision clarity (6 items: 0.61 and 0.63), optimism (6 items: 0.77 and 0.81), health proneness (10 items: 0.85 and 0.84), Patient Health Questionnaire-4 (4 items: 0.80 and 0.81), and socially desirable response set (2 items: 0.56 and 0.51). At the 1-month postoperative assessment, α levels for satisfaction with surgery (8 items) were 0.90 for PROWL-1 and 0.91 for PROWL-2. Test-retest productmoment correlations over a mean interval of 10.74 (3.94) days in PROWL-1 ranged from 0.33 (hours worked) to 0.80 (NEI-RQL-42 clarity of vision and activity limitations) and, over a mean (SD) interval of 6.34 (3.04) days in PROWL-2 ranged from 0.54 (hours worked) to 0.93 (NEI-RQL-42 far vision). The median (interquartile range) test-retest intraclass correlation was 0.69 (0.57-0.79) in PROWL-1 and 0.76 (0.68-0.84) in PROWL-2. The 2 largest correlations among scales at baseline (eTable 3intheSupplement) were between the NEI-RQL-42 far vision and the NEI-VFQ-25 driving scales (PROWL-1, r = 0.81; PROWL-2, r = 0.85) and between the visual symptoms scales of starbursts and halos (r = 0.63 and r = 0.70, respectively).
Construct Validity
Correlations of the new visual symptom measures with satisfaction with surgery were statistically significant in the hypothesized direction: glare (r = 0.34 at 1 month, r =0.36at3 months, and r = 0.43 at 6 months in PROWL-1; r = 0.40 at 1 month and r = 0.33 at 3 months in PROWL-2), starbursts (r = 0.27 at 1 month, r = 0.24 at 3 months, and r =0 . 32a t6 months in PROWL-1; r = 0.36 at 1 month and r =0 . 3 6a t3 months in PROWL-2), halos (r = 0.37 at 1 month, r =0.34at3 months, and r = 0.49 at 6 months in PROWL-1; r =0 . 38a t1 month and r = 0.33 at 3 months in PROWL-2), and double images (r = 0.43 at 1 month, r = 0.37 at 3 months, and r =0.39at 6 months in PROWL-1; r = 0.29 at 1 month and r =0.48at3 months in PROWL-2).
Correlations between baseline expectations of spectacle use and vision with satisfaction with surgery at 1 and 3 months in both studies and at 6 months in PROWL-1 were not significant. The correlation of baseline health proneness with satisfaction with surgery at 3 months was statistically significant but small in magnitude (r = 0.14, P = .04 in PROWL-1 and r = 0.13, P = .04 in PROWL-2). The Patient Health Questionnaire-4 depressive/anxiety score at baseline was significantly associated with satisfaction with surgery at 6 months in PROWL-2, but was small in magnitude (r = −0.19, P = .004). The correlations of satisfaction with surgery with socially desirable response set were small in PROWL-1 (r = 0.13, P = .47 at 1 month and r = 0.15, P = .29 at 3 months) and not significant in PROWL-2 (r = 0.08, P = .17 at 1 month and r = 0.05, P = .46 at 3 months).
Change From Baseline to Follow-up
Changes from baseline to 1 month (Table 3) , 3 months (Table 4) , and 6 months (Table 5) postoperatively are reported. As hypothesized, most of the measures improved significantly in both studies from baseline to the 1-month follow-up, but hours worked, OSDI environment scale, and 2 visual symptoms (starbursts and halos) did not change in either study and the new visual symptoms glare scale did not change in PROWL-1. The NEI-RQL-42 glare scale score significantly worsened from baseline to 1 month postoperatively in both studies.
At the 3-month follow-up, every measure improved significantly except that there was no change from baseline for the NEI-RQL-42 glare scale and hours worked in both studies and for the OSDI environment scale in PROWL-1. At the 6-month follow-up (PROWL-1), all measures improved significantly from baseline with 2 exceptions: hours worked and the OSDI environment scale.
The magnitude of change in PROWL-1 ranged from 0.14 baseline SD (OSDI symptom scale) to 1.86 SD (satisfaction with vision) at 1 month, 0.17 SD (halos symptom scale) to 1.95 SD (satisfaction with vision) at 3 months, and 0.20 SD (NEI-RQL-42 glare scale) to 1.98 SD (satisfaction with vision) at 6 months.
Magnitude of change in PROWL-2 ranged from 0.14 SD (NEI-RQL-42 clarity of vision) to 1.25 SD (satisfaction with vision) at 1 month and 0.19 SD (halos scale) to 1.34 SD (satisfaction with vision) at 3 months. Repeated-measures analyses that included baseline and all follow-up data in a single model produced results similar to those reported here.
Discussion
This study provides support for the reliability and validity of the HRQOL instrument administered in the PROWL studies for patients undergoing LASIK surgery. Content validity was enhanced by input from patients who underwent LASIK and clinicians during development of the new items.
23 Item-scale correlations indicated that the items were almost always more highly correlated with the scale they were intended to represent than with other scales. Reliability estimates exceeded the 0.70 threshold for adequate reliability for most of the measures. In addition, correlations among the scales indicated that they yield distinct information about HRQOL. Moreover, the HRQOL measures were significantly positively correlated with patient satisfaction with LASIK surgery, consistent with a previous study. 24 The measures were uncorrelated or weakly associated with socially desirable response set, health proneness (coping), optimism, depressive and/or anxiety symptoms, and expectations of spectacle use and vision.
Responsiveness to change was supported by improvements in almost every HRQOL measure from baseline to followup. The NEI-RQL-42 glare scale showed increases in glare at 1 month in both PROWL-1 and PROWL-2 and reduction in glare at 6 months in PROWL-1. Differences from baseline for all other follow-up times were not found. A previous evaluation of 185 patients before and 4 months after surgical correction of myopic or hyperopic refractive error found increases in glare among myopes.
12 Unlike the NEI-RQL-42, the new glare items included a definition that focused solely on glare, as well as an image showing graded severity. We found significant improvements (less glare) on the new visual symptoms glare scale at 1 month in PROWL-2, 3 months in PROWL-1 and PROWL-2, and 6 months in PROWL-1.
Limitations and Strengths
Inferences about the prevalence of the symptoms are limited by oversampling of high myopes and hyperopes. In addition, whether the changes observed persist beyond the time intervals studied is unknown. Furthermore, PROWL studies were limited to English-language participants. Administering the questionnaire to people whose English differs from US English or whose primary language is not English would require translation and assessment of the linguistic and cultural equivalence relative to the original English-language questionnaire. Moreover, associations of the PROs with visual acuity were small or not significant and using acuity as a clinical and/or was not supported. Finally, caution in drawing conclusions is warranted because of the multiple statistical tests performed. Despite these limitations, most eligible patients were included in the analysis (99.6% in PROWL-1 and 95% in a All scales are scored ona0to100 possible range. NEI-RQL-42 scales, NEI-VFQ driving scale, visual symptoms scales, and satisfaction with vision are scored such that a higher score is better. OSDI is scored such that a higher score is worse.
b Truncated at 60 hours.
Research Original Investigation
Psychometric Properties of a Questionnaire on Patient-Reported LASIK Outcomes PROWL-2), which is notably better than most surveys. 25 The results of PROWL-1 and PROWL-2 were consistent. The new visual symptom items provide a potentially valuable approach that couples images with definitions and facilitates reports about the impact of surgery. Eight questions for each symptom were used to assess frequency, bother, and difficulty doing usual activities when and when not wearing vision correction. Estimates of the minimally important difference of mean scores are reported in eTable 9 in the Supplement. Supplementary Rasch-model analyses were consistent with the reported results (eTables 10 and 11 in the Supplement). The web-based administration of questionnaires, which allowed for questionnaire completion outside of the clinical visit, facilitated the conduct of the clinical studies by removing 1 level of data entry and potentially provided the participants more anonymity in their responses. Most study participants reported that completing the questions by computer was easier than it would have been to do so by paper.
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Conclusions
The PROWL studies provided support for the reliability and validity of most scales included in the questionnaire for evaluating the effect of LASIK surgery. The newly created measures to assess satisfaction with LASIK surgery and double images, glare, halos, and starbursts supplement the existing OSDI symptoms scale, NEI-RQL-42 scales (clarity of vision, near vision, far vision, diurnal vision, activity limitation, and worry), and the NEI-VFQ-25 driving scale. This collection of measures can be used to help provide estimates of the prevalence of symptoms, functioning, and well-being in future studies evaluating LASIK devices. We recommend use of the new visual symptoms scales, the satisfaction with LASIK surgery scale, and the satisfaction with vision item in future studies. These newly created scales in the PROWL questionnaire could be used to measure important visual symptoms that occur following LASIK. Role of the Funder/Sponsor: The DHHS and the Department of Defense funded and participated in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer:
The mention of commercial products, their sources, or their use in connection with material reported herein is not to be construed as either an actual or implied endorsement of such products by the DHHS. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of We selected the NEI-RQL as the primary legacy measure, but also included the NEI-VFQ driving scale because driving may be affected by LASIK surgery but it is not assessed by the NEI-RQL. In addition, we included the widely-used Ocular Surface Disease Index (OSDI) to assess dry eye symptoms (Schiffman et al., 2000) . 4 The items included in the PROWL studies are shown below.
Item-Scale Correlations and Correlations Among Scales
Item correlations with the scales they measured generally exceeded correlations of the items with other scales, but an item about poor vision in the OSDI dry eye symptoms and environment triggers scale correlated as highly (r = -0.53) with the clarity of vision scale as with the OSDI scale (r = 0.47). A question about clarity of vision using habitual vision correction, including glasses, contact lenses, a magnifier, or nothing at all correlated only r = 0.12 with the clarity of vision scale (see eTable 1 and eTable 2).
Product-moment correlations among the scales at baseline are provided in eTable 3.
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Construct Validity
We present correlations in eTable 4 between vision symptom scores and satisfaction with LASIK surgery (hypothesizing statistically significant, positive associations), and expectations about spectacle use and vision post-surgery, optimism, health proneness, depression/anxiety symptoms, and socially desirable responses (hypothesizing non-significant correlations).
We hypothesized that those with poorer post-operative visual acuity and/or needing to wear some form of vision correction will be less satisfied with surgery and have higher visual symptom scores.
Associations with Visual Acuity
PROWL-1
Product We also dichotomized the sample into myopic or not, and hyperopic at each timepoint the glare scale at 6-months post-surgery.
PROWL-2
Product-moment correlations of PROWL-2 scales with measures of visual acuity are provided in eTable 7. Uncorrected distance binocular visual acuity was associated with satisfaction at 1-month (r=-0.13, p=0.0425) and 3-months (r=-0.29, p<0.0001). Visual aberration scores were not significantly associated with visual acuity at 1-month, but at 3-months uncorrected distance binocular visual acuity was associated with both starbursts (r=-0.15, p=0.0149) and double images (r=-0.20, p=0.0013), while near binocular visual acuity was associated with double images (r=-0.13, p=0.0473). There were only three people at 1-month post-surgery and four people at 3-months post-surgery who reported needing to wear some form of vision correction.
We also dichotomized the sample into myopic or not, and hyperopic or not at each timepoint (eTable 8). There were 530 eyes with myopia (265 left and right) and 12 eyes with hyperopia at baseline (6 left and 6 right). There were no emmetropes. At one-month postsurgery, non-myopes (left eye) scored higher (better) on the double vision scale than myopes (mean= 98.0 vs 93.1, t=2.5, p=0.0133) while all 40 non-myopes (right-eye) at 3-months scored better as well (mean=100 vs 96.6, t=3.59, p=0.0004).
© 2016 American Medical Association. All rights reserved. 5
Interpretation of Scores
All scales with the exception of OSDI are scored so that a higher score is more positive.
Prior work indicates that the minimally important differences (MIDs) in HRQOL measures are often in the range of 0.20-0.30 effect size in magnitude (Revicki et al., 2008) . 5 We estimated MIDs in the PROWL studies using the satisfaction with vision item as an anchor:
SAT_VIS:
In general, how satisfied or dissatisfied are you with your present vision?
Completely satisfied
Very satisfied
Somewhat satisfied
Somewhat dissatisfied
Very dissatisfied
Completely dissatisfied
We defined four change groups from baseline to the 3-month follow-up: 1) those who reported being less satisfied at the 3 month follow-up than at baseline (worse); 2) those who reported the same level of satisfaction at the 3 month follow-up as at baseline (stayed the same); 3) those who reported greater satisfaction by 1 response category at the 3-month follow-up compared to baseline (improved by a minimally important amount), and 4) those who reported greater satisfaction by 2 or more categories at the 3-month follow-up compared to baseline (much better). Changes on the PROWL scales by the change groups based on satisfaction with vision are shown in eTable 9. These results suggest that changes of about 0.30 of a SD or higher are important.
Rasch Modeling
As a sensitivity analysis we examined alternative scoring of the new visual symptom items using a Rasch (1960) model-that is, slopes were constrained to be equal across items within a scale. We evaluated the Rasch assumptions of unidimensionality and local independence using Mplus version 7.0 (Muthén & Muthén, 2012). 6 We estimated Rasch location parameters and scores using IRTPRO 2.1 (Cai et al., 2011).
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Factor analyses provided support for separating items by whether they referred to use of corrective lenses. We fixed item slopes and estimated item location parameters to estimate Rasch model scores (three-item scales assessing symptoms when not wearing best vision correction, and four-item scales assessing symptoms when wearing best vision correction) using only respondents who reported having the symptom. These item parameters were used to obtain eight scale scores (latent trait estimates) for all study participants. We transformed the Rasch scores to a T-score metric (mean = 50, SD = 10) for a pooled sample that included all assessments in PROWL-1 and PROWL-2. As shown in eTables 10 and 11, these analyses indicated significant improvements in all eight scores from baseline to each follow-up time point (one-month, three-months, and six-months) except for the one-month follow-up for halos (both for not wearing best vision correction and for best vision correction) and for starbursts (for not wearing best vision correction). The median effect size for significant change over time for the eight scale scores was 0.32 (SD on the latent trait metric). 
Items included in the PROWL
Clarity of vision (4 items)
At During the past seven days, how much did eye problems affect your productivity while you were working? Eye problem(s) Eye problem(s) 0 = had no effect on 10 = completely prevented me from my work working
During the past seven days, how much did eye problems affect your ability to do your regular daily activities, other than work at a job? Eye problem(s) Eye problem(s) 0 = had no effect on 10 = completely prevented me from my daily activities doing my regular activities
New Items Visual symptoms Double images (8 items)
In In the last 7 days, how bothersome has the glare been when you are wearing your best vision correction (glasses or contact lenses)? scores were computed using the items about the frequency, amount of bother, difficulty performing activities due to the symptom, and if symptom goes away when using best vision correction. SD = standard deviation. Note: The 6-month means were calculated using only PROWL-1 data.
